The open-market selling is minor relative to company size and appears related to personal tax and liquidity management following equity vesting. No red flags in fundamentals, but traders should monitor for any pattern of increasing insider selling in future filings.
Price Chart
Executive Summary
United Therapeutics CEO Martine Rothblatt and other insiders engaged in a series of derivative exercises and open-market sales over the past week, with total open-market sales by insiders amounting to approximately $1.28 million. The majority of the activity consists of non-cash transactions (derivative exercises and tax withholdings), including a large tax-related share surrender worth $7.3 million by the CEO. The open-market selling was modest in dollar terms relative to the company's $23.1B market cap.
Key Financial Metrics
Key Facts
- CEO Martine Rothblatt sold 1,657 shares in open-market transactions totaling ~$1.07 million at prices between $522.88 and $534.99.
- EVP Paul Mahon sold 753 shares in open market for ~$397K.
- Director Malcolm Jan sold 45 shares for ~$24K; Director Judy Olian sold 200 shares for ~$107K.
- CEO and EVP exercised derivatives totaling 9,500 and 8,300 shares respectively on multiple dates, with exercise prices of $146.03 and $0.
- CEO surrendered 13,637 shares for tax withholding purposes (~$7.3M value); EVP surrendered 4,457 shares (~$2.39M).
- Total open-market sales by insiders in the cluster: ~$1.28 million.
- Total value of non-cash transactions (M, A, F): ~$12.7 million.
Financial Impact
$1.28 million in open-market selling over 7 days, representing 0.0055% of market cap
Risk Factors
- Perception of insider profit-taking, though at a very small scale
- Large tax withholdings could signal significant vesting events, which may recur
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (20 trades, 7d window) | cluster-UTHR-1774038735009 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $500.35 $497.31 | ▼ −0.61% | ▼ −2.72% | $571.38 (+14.20%) |
Sep 11, 2026 21d ago | Insider Cluster | $497.11 $494.63 | ▼ −0.50% | ▼ −0.28% | $571.38 (+14.94%) |
Sep 10, 2026 22d ago | Insider Cluster | $503.86 $497.27 | ▼ −1.31% | ▼ −0.81% | $571.38 (+13.40%) |
Sep 9, 2026 23d ago | Insider Cluster | $506.82 $498.48 | ▼ −1.65% | ▼ −0.99% | $571.38 (+12.74%) |
Sep 4, 2026 28d ago | Insider Cluster | $487.61 $502.70 | ▲ +3.09% | ▲ +4.30% | $571.38 (+17.18%) |
Sep 3, 2026 29d ago | Insider Cluster | $488.16 $497.11 | ▲ +1.83% | ▲ +2.98% | $571.38 (+17.05%) |
Aug 28, 2026 5w ago | Insider Cluster | $515.46 $487.61 | ▼ −5.40% | ▼ −5.51% | $571.38 (+10.85%) |
Aug 27, 2026 5w ago | Insider Cluster | $527.91 $492.02 | ▼ −6.80% | ▼ −6.03% | $571.38 (+8.23%) |
Aug 26, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $571.38 (+10.59%) |
Aug 25, 2026 5w ago | Insider Cluster | $516.68 $492.02 | ▼ −4.77% | ▼ −4.65% | $571.38 (+10.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access